Corresponding with this, while IL-2 blockade increases human Tfh cell differentiation in vitro (156), treatment with low-dose rIL-2 reduces the frequency of Tfh cells in SLE patients (143). This evidence concerns the gene IL2 and systemic lupus erythematosus.